CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 173 filers reported holding CASSAVA SCIENCES INC in Q1 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,935,839 | -43.3% | 717,298 | -16.5% | 0.00% | -40.0% |
Q2 2023 | $21,052,995 | -21.3% | 858,605 | -22.6% | 0.01% | -16.7% |
Q1 2023 | $26,752,867 | -26.9% | 1,109,157 | -10.5% | 0.01% | -25.0% |
Q4 2022 | $36,618,788 | -48.5% | 1,239,634 | -27.1% | 0.01% | -50.0% |
Q3 2022 | $71,069,000 | +61.4% | 1,699,400 | +8.5% | 0.02% | +33.3% |
Q2 2022 | $44,029,000 | -15.4% | 1,565,749 | +11.8% | 0.01% | +9.1% |
Q1 2022 | $52,018,000 | -25.3% | 1,400,600 | -12.1% | 0.01% | -21.4% |
Q4 2021 | $69,636,000 | -36.6% | 1,593,500 | -9.9% | 0.01% | -39.1% |
Q3 2021 | $109,810,000 | +45.1% | 1,768,856 | +99.7% | 0.02% | +35.3% |
Q2 2021 | $75,660,000 | +120.8% | 885,538 | +16.2% | 0.02% | +88.9% |
Q1 2021 | $34,261,000 | +1776.3% | 762,229 | +184.6% | 0.01% | – |
Q4 2020 | $1,826,000 | -48.2% | 267,778 | -12.6% | 0.00% | -100.0% |
Q3 2020 | $3,526,000 | +301.6% | 306,289 | +7.3% | 0.00% | – |
Q2 2020 | $878,000 | +280.1% | 285,349 | +408.0% | 0.00% | – |
Q1 2020 | $231,000 | +755.6% | 56,173 | +171.0% | 0.00% | – |
Q1 2019 | $27,000 | – | 20,731 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |